Literature DB >> 23051986

[Osteoporotic fractures of the proximal femur. What's new?].

F Bonnaire1, C Straßberger, M Kieb, P Bula.   

Abstract

Proximal femoral fractures in the elderly are still increasing and are almost always associated with osteoporosis. Especially the over 80-year-olds are increasing and at risk in this respect. In the treatment of these patients new knowledge has been achieved over the last years. An interdisciplinary, multimodal approach with early involvement of internists, geriatricians, anesthetists, osteologists, social workers, care facilities and outpatient trauma and orthopedic surgeons seems to generate a better outcome with fewer complications. In cases of suspected proximal femoral fracture diagnostic imaging should include a computed tomography scan of the posterior pelvic ring to detect commonly occurring fragility fractures of the lateral mass of the sacrum. Early surgery within the first 48 h has a significant positive effect with respect to general and local complications and early mortality. Medical and organizational barriers to an early operation, such as anticoagulant medication, limited capability of communication due to mental dysfunction and lack of operation capacity are continuously declining and subsequently complication rates are decreasing annually in Germany. Endoprosthetics are still associated with higher perioperative mortality than osteosynthesis (4.4 % versus 5.8 %). The innovations in the field of implants and surgical technique also contribute to these lower complication rates. While endoprosthetic treatment is still the gold standard for severely dislocated femoral neck fractures, non-dislocated or slightly dislocated fractures should be fixed with a stable extramedullary implant. For pertrochanteric fractures extramedullary stabilization can only be recommended for stable types of fractures. Every instable trochanteric fracture should be fixed with an intramedullary implant. The use of third generation nails has implicated a significant reduction of complication rates regarding cut-out and reoperations. Rotational fixing of the head-neck fragment with angular stable blade systems and the option of polymethyl-methacrylate (PMMA) cement augmentation are promising advantages that still remain to be clinically tested. Endoprosthetic treatment of pertrochanteric femoral fractures still has 3 times higher complication rate and is implemented only in exceptional situations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23051986     DOI: 10.1007/s00104-012-2340-8

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  34 in total

1.  The new proximal femoral nail antirotation (PFNA) in daily practice: results of a multicentre clinical study.

Authors:  R K J Simmermacher; J Ljungqvist; H Bail; T Hockertz; A J H Vochteloo; U Ochs; Chr v d Werken
Journal:  Injury       Date:  2008-06-25       Impact factor: 2.586

2.  Management of osteoporosis-related bone fractures: an integrated concept of care.

Authors:  Carsten Strassberger; Leonore Unger; Andreas T Weber; Alexander Defer; Felix A Bonnaire
Journal:  Arch Orthop Trauma Surg       Date:  2009-11-03       Impact factor: 3.067

3.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

4.  Multicenter trial of modified Gamma nail in East Asia.

Authors:  K S Leung; C M Chen; W S So; K Sato; C H Lai; B Machaisavariya; S Suntharalingam
Journal:  Clin Orthop Relat Res       Date:  1996-02       Impact factor: 4.176

Review 5.  [Trochanteric femoral fractures: anatomy, biomechanics and choice of implants].

Authors:  F Bonnaire; T Lein; P Bula
Journal:  Unfallchirurg       Date:  2011-06       Impact factor: 1.000

Review 6.  Coordinator-based systems for secondary prevention in fragility fracture patients.

Authors:  D Marsh; K Akesson; D E Beaton; E R Bogoch; S Boonen; M-L Brandi; A R McLellan; P J Mitchell; J E M Sale; D A Wahl
Journal:  Osteoporos Int       Date:  2011-05-24       Impact factor: 4.507

7.  Comparative study of trochanteric fracture treated with the proximal femoral nail anti-rotation and the third generation of gamma nail.

Authors:  Xu Yaozeng; Geng Dechun; Yang Huilin; Zhu Guangming; Wang Xianbin
Journal:  Injury       Date:  2010-12       Impact factor: 2.586

8.  Initial promising results of the dynamic locking blade plate, a new implant for the fixation of intracapsular hip fractures: results of a pilot study.

Authors:  W H Roerdink; A M M Aalsma; G Nijenbanning; A D P van Walsum
Journal:  Arch Orthop Trauma Surg       Date:  2010-10-21       Impact factor: 3.067

9.  Tip-apex distance of intramedullary devices as a predictor of cut-out failure in the treatment of peritrochanteric elderly hip fractures.

Authors:  Jeffrey A Geller; Comron Saifi; Todd A Morrison; William Macaulay
Journal:  Int Orthop       Date:  2009-07-18       Impact factor: 3.075

Review 10.  Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults.

Authors:  Martyn J Parker; Helen Hg Handoll
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08
View more
  3 in total

1.  [Osteological interdisciplinary management : exemplified by a bilateral proximal humeral fracture].

Authors:  C Neuerburg; K Pietschke; U Stumpf; S Sommerey; R Schmidmaier; B Ockert; W Böcker; F Haasters
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

Review 2.  [Proximal femoral fractures in the elderly].

Authors:  Carl Neuerburg; M Gosch; W Böcker; M Blauth; C Kammerlander
Journal:  Z Gerontol Geriatr       Date:  2015-10       Impact factor: 1.281

3.  Hip Fractures: Therapy, Timing, and Complication Spectrum.

Authors:  Dominik Saul; Juliane Riekenberg; Jan C Ammon; Daniel B Hoffmann; Stephan Sehmisch
Journal:  Orthop Surg       Date:  2019-09-30       Impact factor: 2.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.